City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
Click here to login to Secure Web Site  (authorized users only)  
  
Search results:  54  Clinical trial(s) found  (Page 1 of 11 )
  [Next>]
Click here to generate a printer-friendly view  
The following studies are available for :
 09148
   P.I.: Robert Chen, MD
Title: SGN-35-008 An Open Label Clinical Pharmacology Study of Bretnuximab Vedotin (SGN-35) in Patients with CD-30 Positive Hematologic Malignancies: CYP3A
 
Click here for  Full Eligibility Criteria
 09129
   P.I.: Vincent Chung, MD
Title: A Phase IA, Multicenter, Open-Label Dose Escalation Study of BKM120, Administered Orally in Adult Patients with Advanced Solid Malignancies
 09128
   P.I.: Mihaela Cristea, MD
Title: A Phase Ib, Parallel Arm, Multicenter, Open-Label Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination with Two Different Chemotherapy Regimens in Women with Platinum Resistant or Platinum Sensitive Ovarian Cancer
 
Click here for  Full Eligibility Criteria
 09082
   P.I.: Karen Reckamp, MD
Title: Phase 1b Open label, Dose Escalation Study of AMG 655 in Combination with AMG 479 in Subjects with Advanced, Refractory Solid Tumors
 
Click here for  Full Eligibility Criteria
 09079
   P.I.: George Somlo, MD
Title: A Phase Ib Multiple Ascending Dose Study of BMS-833923 (XL 139) Alone or in Combination with Lenalidomide (Revlimid) Plus Dexamethasone or in Combination with Bortezomib (Velcade) in Subjects with Relapsed or Refractory Multiple Myeloma, BMS CA 194003
 
Click here for  Full Eligibility Criteria
  [Next>]

  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.